- Home
- VMD vs HRTX Comparison
VMD vs HRTX Comparison
Compare VMD & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VMD | HRTX |
|---|---|---|
| Founded | 2006 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 369.2M | 228.3M |
| IPO Year | 2018 | 2007 |
Fundamental Metrics
Financial Performance| Metric | VMD | HRTX |
|---|---|---|
| Price | $9.97 | $0.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 208.5K | ★ 3.6M |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.14 | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $270,280,000.00 | $154,904,000.00 |
| Revenue This Year | $17.88 | $15.28 |
| Revenue Next Year | $14.98 | $20.29 |
| P/E Ratio | $164.00 | ★ N/A |
| Revenue Growth | ★ 20.52 | 7.36 |
| 52 Week Low | $5.93 | $0.43 |
| 52 Week High | $10.18 | $2.30 |
Technical Indicators
Market Signals| Indicator | VMD | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 57.87 | 21.39 |
| Support Level | $9.22 | N/A |
| Resistance Level | $10.05 | $1.34 |
| Average True Range (ATR) | 0.32 | 0.06 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 93.53 | 0.50 |
Price Performance
Historical ComparisonAbout VMD Viemed Healthcare Inc.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.